Related Experiment Video

Updated: May 25, 2026

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

A negative screen for mutations in calstabin 1 and 2 genes in patients with dilated cardiomyopathy

Diogo G Biagi1, José G Mill, Alfredo J Mansur

  • 1Laboratory of Genetic and Molecular Cardiology, Heart Institute, University of Sao Paulo Medical School, Brazil.

Journal of Negative Results in Biomedicine
|January 13, 2012
PubMed
Abstract

Insights

Genetic screening of calstabins 1 and 2 (FKBP12 and FKBP12.6) in dilated cardiomyopathy patients found no disease-causing mutations. These findings suggest calstabin gene mutations are not a common cause of cardiac disease.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Calstabins 1 and 2 regulate muscle excitation-contraction coupling by binding to Ryanodine receptors.
  • Mutations affecting calstabin-Ryanodine receptor interactions are linked to cardiac pathologies.
  • Animal models suggest calstabins play a role in dilated cardiomyopathy.

Purpose of the Study:

  • To investigate the hypothesis that calstabin mutations cause dilated cardiomyopathy in humans.
  • To screen for genetic alterations in calstabin 1 (FKBP12) and calstabin 2 (FKBP12.6) genes in patients with idiopathic dilated cardiomyopathy.

Main Methods:

  • Genetic screening of 186 patients with idiopathic dilated cardiomyopathy.
  • Analysis of calstabin 1 (FKBP12) and calstabin 2 (FKBP12.6) genes for mutations.
  • Identification and characterization of genetic variations.

Main Results:

  • No missense variants were identified in the FKBP12 and FKBP12.6 genes.
  • Five non-coding variations were detected but were not associated with the disease.
  • The study found no direct genetic link between calstabin mutations and dilated cardiomyopathy in the screened population.

Conclusions:

  • The study's findings do not support a common role for FKBP12 and FKBP12.6 gene mutations in causing dilated cardiomyopathy.
  • These results align with previous research indicating that calstabin mutations are infrequent causes of cardiac disease.
  • Further research may be needed to explore other genetic or environmental factors contributing to dilated cardiomyopathy.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes09:41

Visualization of Cell Cycle Variations and Determination of Nucleation in Postnatal Cardiomyocytes

Published on: February 24, 2017

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...